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Background: There is little information available on the features of initial
presentation of bronchiectasis and documentation of the onset and progress of
symptoms leading up to this. Therefore a study was performed on a large cohort of
adult patients presenting to Monash Medical Centre (MMC) to survey the course of
their disease up to the time of diagnosis.
Objectives: To characterise the onset and presenting clinical features of bronch-
iectasis in adults.
Methods: A cross-sectional study of 103 adults presenting to a tertiary referral
hospital with newly diagnosed bronchiectasis. Clinical features of bronchiectasis and
results of spirometry, sputum microbiology and radiology were assessed and
correlated.
Results: Most patients had idiopathic bronchiectasis (74%) and did not have other
signiﬁcant disease. The dominant symptom was chronic productive cough present in
98% of patients with other important symptoms being chronic rhinosinusitis (70%),
dyspnoea (62%), and fatigue (74%). Most patients had had a chronic productive cough
for over 30 years prior to diagnosis and over 80% of patients had chronic respiratory
symptoms from childhood. The dominant ﬁnding on physical examination was the
presence of crackles which were generally bi-basal. Spirometry showed mild airway
obstruction with an average forced expiratory volume in 1 s of the cohort of 76%
predicted. Radiologic imaging generally showed multilobar disease (80%).Elsevier Ltd. All rights reserved.
of Respiratory Medicine, Monash Medical Centre, 246 Clayton Rd, Clayton, Melbourne,
66; fax: 61 3 9594 6415.
nash.edu.au (P.T. King).
ARTICLE IN PRESS
P.T. King et al.2184Conclusions: The typical proﬁle of bronchiectasis in this group of patients was of
longstanding productive cough, rhinosinusitis and fatigue in non-smokers with
crackles on chest auscultation.
& 2006 Elsevier Ltd. All rights reserved.Introduction
Bronchiectasis is a classic respiratory condition
whose clinical proﬁle and presentation has changed
signiﬁcantly since the introduction of antibiotics. A
large study performed in 1940 assessed 400
subjects with bronchiectasis. In this study bronch-
iectasis was associated with a mortality rate of over
30% (in the follow-up period of 2–12 years) with
most patients dying before the age of 40.1 The
introduction of antibiotics caused a signiﬁcant
change in the proﬁle of this disease and a retro-
spective study in 19812 found a signiﬁcantly better
outcome with a mortality rate of 13%. Despite the
introduction of antibiotics bronchiectasis continues
to be an important cause of chronic respiratory
disease particularly that with the advent of high-
resolution computerised tomography (HRCT) the
diagnosis is much easier to make. In a study of 110
patients diagnosed as having chronic obstructive
pulmonary disease (COPD) by general practitioners,
29% of these subjects were found to have bronch-
iectasis according to currently accepted CT scan-
ning criteria3 suggesting that this condition remains
relatively common and under diagnosed. Few
articles have documented the clinical features of
this condition in the past 20 years. In particular,
there is very little information available on the
features of initial presentation of this condition and
documentation of the onset and progress of
symptoms leading up to this. Therefore a study
was performed on a large cohort of adult patients
presenting to Monash Medical Centre (MMC) to
survey the course of their disease up to the time of
diagnosis.Methods
Study subjects
A series of 145 adult patients with bronchiectasis
was seen at MMC between 1980 and 2001. The
diagnosis of bronchiectasis was conﬁrmed by
bronchogram or CT scanning after review by a
consultant radiologist. There were 103 new diag-
noses of bronchiectasis in this cohort (8 from
bronchogram and 95 from CT) and these newlydiagnosed patients were selected for further
analysis.Methods
All 103 subjects had detailed clinical assessment
performed at MMC with a standard proforma to
record ﬁndings at the time of diagnosis. Patients
were asked about the presence and frequency of
productive cough, sputum volume (sputum volume
was estimated by comparison with a teaspoon
(5ml), tablespoon (15ml), eggcup (50ml) and
teacup (150ml)). Details were also obtained about
presence of rhinosinusitis, chest pain, haemoptysis
in the past 5 years, fatigue/lethargy, frequency of
exacerbations (deﬁned by a sustained worsening in
their clinical state with at least one of: increase in
sputum volume, dyspnoea or fever) and symptoms
of dyspnoea using the Medical Research Council
(MRC) dyspnoea grade. Subjects were asked about
the initial onset and progression of their symptoms,
childhood respiratory disease, general health
(including questioning about symptoms of autoim-
mune disease and arthritis) and tobacco consum-
ption. Findings on physical examination were also
recorded.
Ethical approval for this project was obtained
from the Southern Health Ethics Committee, MMC.
Subjects had spirometry performed for forced
expiratory volume in 1 s (FEV1), forced vital
capacity (FVC) and bronchodilator (BD) response
to inhaled salbutamol at MMC. At least 2 measure-
ments differing by less than 5% or 100ml from each
other had to be produced. The largest volume was
used in this analysis. Spirometers were calibrated
daily. Patients were also asked to produce a sputum
sample which was analysed by microscopy and
culture. To assess for predisposing factors for
bronchiectasis, all subjects had blood taken for
full blood examination, immunoglobulin levels
(including subclasses) and alpha1-antitrypsin levels
and where clinically indicated further investi-
gations for cystic ﬁbrosis (multiple mutation ana-
lysis/sweat testing; done if widespread severe
bronchiectasis), ciliary function (done for unex-
plained infertility), and allergic bronchopulmonary
aspergillosis (aspergillus precipitins and skin test
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Table 1 Demographic data on patients with
newly diagnosed bronchiectasis.
Number of patients 103
Age, years (mean7SD) 56714
Sex ratio
Male, n (%) 38 (37)
Female, n (%) 65 (63)
Smoking History
Lifetime non-smokers, n (%) 79 (77)
Smokers/ex-smokers, n (%) 24 (23)
Pack years (mean7SD) 24714 years
Patients with idiopathic
bronchiectasis, n (%)
76 (74)
Diagnostic features of bronchiectasis 2185reactions; done if there was central bronchiectasis,
signiﬁcant asthma or eosinophilia).
The FEV1 has been shown to be the most
important measure of outcome in COPD.4 FEV1 has
not been reported in detail in the context of
bronchiectasis but it is an important measurement
of lung function in this condition. A number of
factors have been shown to affect FEV1 in COPD.
5 In
this study, factors that have been shown to affect
the outcome of FEV1 in COPD were looked at in
addition to speciﬁc factors associated with infec-
tion in bronchiectasis. The factors were; volume of
sputum, duration of chronic productive cough,
frequency of exacerbations, history of smoking,
asthma/signiﬁcant BD effect (deﬁned as415% BD
effect after inhaled b agonist), extent of disease on
X-ray (bronchogram or CT scanning) and type of
bacteria isolated from sputum. All these factors
were correlated with the FEV1.
Analysis
In all analyses, a Type I error rate (the probability
of detecting a statistically signiﬁcant association
when none exists) was set at 5%. Statistical analysis
was performed using either Stata SE 8.0 (College
Station, Texas) or Prism 2 (California, USA) soft-
ware. Conventional descriptive measures of the
middle (e.g., mean, median) and spread (e.g.,
standard deviation, interpercentile ranges) were
derived for continuous variables, as well as cross-
tabulations for categorical variables. Comparisons
between categorical variables used the Pearson’s w2
statistic (or the Fisher’s exact test for small
samples). When comparing continuous outcome
variables by categorical predictors, the Student’s
t-test was used (or its non-parametrical equivalent,
the Wilcoxon rank sum test). The major outcome of
interest, FEV1 was expressed as percent predicted
for age, sex, and height. Multiple linear regression
was used to analyse FEV1 as a continuous variable
(from low to high) with other variables. All
variables were included in this regression analysis.Results
Demographic data of the patients are shown in
Table 1. Results are shown for number (n) and
percentage of patients. The mean (SD) age of the
group was 56(14) years and the majority of patients
were female. Twenty four out of the 103 subjects
had a history of smoking which is lower than the
expected rate in a group of this age (the expected
rate of subjects with a smoking history in Australiais 460%6) (Po0.0001, using the w2 statistic), and
only 7 of the patients were still smoking at the time
of review. In patients who had a history of smoking
in all but three cases, chronic respiratory symptoms
had started before their smoking habit.
The great majority (76 patients) in this cohort
were classiﬁed as having idiopathic disease. Ten
patients were classiﬁed as being post-infective
(deﬁned as chronic cough and sputum production
directly after pneumonia, tuberculosis, whooping
cough or measles), 9 had isolated IgG subclass
deﬁciency (2 had low IgG2 levels and 7 had low IgG3
levels) 4 had allergic bronchopulmonary aspergil-
losis, one patient had Kartagener’s syndrome, one
patient had Young’s syndrome, and two subjects
had associated rheumatoid arthritis.
Of the patients, 11 had a previous diagnosis of
asthma and 3 had COPD (diagnosed in smokers with
non-reversible airway obstruction). Apart from
their bronchiectasis patients generally did not have
other major illnesses and were all living indepen-
dently.
All but 2 of the 103 subjects had a history of
chronic productive cough (Table 2). The great
majority of patients also complained of daily
sputum production that was generally mucopuru-
lent and averaged over 30ml in volume per day.
Over half of the patients complained of dyspnoea
which was generally mild in severity. Rhinosinusitis
(deﬁned as chronic upper respiratory tract symp-
toms present for more than a year) was a very
common symptom and varied from mild intermit-
tent nasal discharge to severe purulent sinusitis.
Thirty of the patients gave a history of previous
ear nose and throat (ENT) surgery, generally for
recurrent sinusitis and 47 of the patients had
radiologic abnormalities of the upper airway (ran-
ging from mucosal thickening to severe pansinusi-
tis). Over half the patients described having sputum
with ﬂecks of blood at some stage but a smaller
ARTICLE IN PRESS
Table 2 Clinical Findings in 103 patients with
bronchiectasis at time of diagnosis.
Symptoms, n (%) or mean7SD as appropriate
Productive cough 99 (96)
Sputum most days of week 90 (87); daily
in 78 (76)
Daily sputum volume, ml 38734
Dyspnoea 62 (60)
MRC dyspnoea score 2.171.2
Rhinosinusitis 73 (71)
Chest pain 20 (19)
Exacerbations 2.471.6
Haemoptysis 27 (26)
Fatigue 75 (73)
Signs, n (%)
Crackles 75 (73)
Wheeze 22 (21)
Clubbing 2 (2)
Table 3 Reason for initial referral to MMC in the
group of 103 patients, n (%).
Productive cough 55 (53)
Follow up after pneumonia/chest
infection
18 (18)
Combination of chronic respiratory
symptoms
9 (9)
Haemoptysis 5 (5)
Assessment of poorly controlled asthma 3 (3)
Dry cough 2 (2)
Chest pain 2 (2)
Other 9 (9)
Hospitalisation in past year 7 (7)
Table 4 Spirometry/radiology ﬁndings.
Spirometry
FEV1
Litres (mean and SD) 1.9270.74
% predicted (mean and SD) 76726
FVC
Litres (mean and SD) 2.8272.82
% predicted (mean and SD) 89725
FEV1/FVC 67.7
4 15% reversibility after BD 21 (patients)
Radiology (CT/bronchogram)
Patients with multilobar disease 82
Lobes involved
RUL 13
RML 30
RLL 71
LUL 25
LLL 66
P.T. King et al.2186number (27 patients) described having frank hae-
moptysis in the past 5 years which was a cause of
considerable concern and generally resulted in
immediate medical consultation. A quarter of the
patients described having non-ischemic chest pain,
which was generally either pleuritic or musculos-
keletal in nature. Most patients complained of
fatigue/lethargy which interfered with their qual-
ity of life, and a number of them felt this was the
most dominant symptom.
Physical examination showed the presence of
crackles in most patients which were generally
basal in their distribution. Wheeze was the other
common examination ﬁnding. Only two patients
were clubbed.
Over half of patients (55) were initially referred
to MMC for the investigation of chronic productive
cough (Table 3). The next most common reason for
referral was for follow up after an episode of
pneumonia in 18 patients.
Spirometry of the group was characterised by
mild airway obstruction (Table 4). The FEV1 of the
group was 76% of predicted with a standard
deviation of 26%. The FEV1/FVC ratio was 67.7
and 41 subjects had an FEV1/FVC ratio of o0.7.
Twenty-three patients showed signiﬁcant airway
reversibility after inhaled b agonist. The number of
patients who had a previous diagnosis of asthma or
signiﬁcant airway reversibility was 29.
Radiological examination showed that most
patients (80%) had 2 or more lobes showing
evidence of bronchiectasis and the most common
pattern was bilateral lower lobe involvement
(Table 4). The most commonly involved lobe was
the right lower lobe (RLL) which was affected in69% of patients. The lobe with the least involve-
ment was the right upper lobe (RUL) affected in
13%.
Sputum samples appropriate for microbiological
examination were obtained in 94 subjects. The
most commonly isolated bacterium was Haemophi-
lus inﬂuenzae which was found in 34 subjects
(Table 5). Other common bacteria were Moxarella
catarrhalis (9 patients), Pseudomonas aeruginosa
(7 patients) and Staphylococcus aureus (5
patients). Thirty-six patients had no pathogenic
bacteria isolated.
Subjects were asked as some detail about the
commencement of chronic respiratory symptoms.
The most common symptom was a chronic produc-
tive cough which was present in 98% of patients. In
over 65% of patients this symptom started in
childhood with the most common time of onset
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Table 5 Results of microbiology from sputum
samples of 94 patients.
Bacteria Numbers of
patients (%)
Haemophilus inﬂuenzae 34 (36)
Moxarella catarrhalis 9 (10)
Pseudomonas aeruginosa 7 (7)
Staphylococcus aureus 5 (5)
Streptococcus pneumoniae 5 (5)
Mycobacterium avium complex 1 (1)
Mixed growth 4 (4)
Normal bacterial ﬂora/no growth 36 (38)
Table 6 Factors associated with low FEV1.
Factor P value
Daily volume of sputum 0.660
Duration of chronic cough 0.334
Asthma/BD effect 0.140
Frequency of exacerbations 0.856
History of smoking 0.001
Number of lobes involved 0.005
Bacteria in sputum
H. inﬂuenzae 0.630
S. pneumoniae 0.860
M. catarrhalis 0.152
S. aureus 0.562
P. aeruginosa 0.037
Mixed growth 0.193
No growth 0.704
Diagnostic features of bronchiectasis 2187being in the ﬁrst decade of life. Of the group, 19
remembered having pneumonia in childhood, 11
whooping cough and 5 measles. In only 8 of these
subjects was there a clear association between
these infections and the onset of chronic respira-
tory symptoms.
Well over 80% of subjects complained of chronic
respiratory symptoms in childhood which in addi-
tion to chronic cough included wheeze, asthma,
and recurrent upper and lower respiratory tract
infections that interfered with schooling. Of inter-
est was the observation by over half of patients
that the chronic symptoms tended to improve in
early adulthood and then often became worse in
middle age (over 50 years) when they were often
ﬁrst referred for specialist investigation. Most
patients had as a productive cough for 30 years
before the diagnosis of bronchiectasis was made.
Most patients had been seen by a variety of medical
practitioners, the most common diagnoses in the
ﬁrst 10 years of their symptoms being wheezy
bronchitis, asthma and COPD. Many patients were
not aware of having any speciﬁc diagnosis in this
time.
A number of variables were correlated with the
FEV1 results (volume of sputum, duration of chronic
productive cough, frequency of exacerbations,
history of smoking, asthma/signiﬁcant BD effect,
extent of disease on CT scanning and type of
bacteria).
Three factors were found to have a signiﬁcant
association with FEV1 (Table 6). They were; history
of smoking, extent of disease on X-ray and P.
aeruginosa isolation from sputum.Discussion
We have assessed 103 patients with adult bronch-
iectasis to help deﬁne the typical presenting
features of this condition and to understand theclinical course of the disease leading up to this
time.
The reason for initial referral in over half of
patients was for chronic productive cough with the
next most common reason being after an episode of
pneumonia. Generally this cough had been present
for over 30 years and particularly as most patients
were not smokers the reason why it had taken so
long to diagnose bronchiectasis is not clear. It may
reﬂect a combination of factors, principally low
awareness on the behalf of the medical profession
but also lack of referral/availability for HRCT.
In this study two thirds of subjects were female
similar to other recent studies.14,17,18 The reason
for this sex difference is not clear. There were also
a low number of smokers in this cohort, similar to
another article.18 This may be due to most patients
having a productive cough since childhood which
became worse on smoking.
Over 70% of the subjects in this cohort had
idiopathic disease. Ten of the subjects recalled
chronic respiratory symptoms directly commencing
after an infectious insult which is lower than in
some previous series particularly those from before
1980.1,2,8–12 The attribution of factors precipitat-
ing/preceding bronchiectasis relies generally on
long-term retrospective recall and there may
previously have been over-ascription to infective
causes.13 There is evidence to suggest that the
spectrum of bronchiectasis has changed in the
antibiotic era and now this disease which has a
large number of possible causes and associations is
most commonly idiopathic.13,14 The most compre-
hensive recent assessment of the aetiology of
bronchiectasis has been performed by Pasteur
et al.14 This study found that 32% of subjects had
an immune defect/associated condition compared
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P.T. King et al.2188with 17% for the current study. Factors that may
explain the difference between the 2 studies
include a more comprehensive assessment used by
Pasteur et al. and the possibility that the 2 groups
may differ in their underlying characteristics.
Rhinosinusitis which has not always been con-
sidered to be a primary feature of bronchiectasis
has also been described to be very common in two
other studies with a rate of more than 60%.15,16
After a chronic cough the most common and
troublesome symptom for patients was chronic
fatigue/lethargy. Chest pain was present in 19% of
subjects at the time of diagnosis; in some cases this
was pleuritic and on other occasions was muscu-
loskeletal but commonly the origin of the chest
pain was not clear. Clubbing often thought of as
being a classic sign in bronchiectasis was found in
only two patients and this is consistent with
another recent study,17 possibly reﬂecting the
milder spectrum of disease in the current era.
Spirometry in most cases showed mild reduction
in lung function with airway obstruction being the
predominant pattern. Almost 30% of patients had a
previous diagnosis of asthma or signiﬁcant airway
reversibility after inhaled b agonist. A previous
study showed a BD rate of 40% in a cohort of
subjects with bronchiectasis.7
As in previous studies14,18,19 the most commonly
isolated bacteria was Haemophilus inﬂuenzae.
There was a relatively low isolation of P. aeruginosa
possibly reﬂecting the fact the lung function of
most patients was not severely impaired and they
had had a low rate of hospitalisation.
Over 80% of the subjects described having some
chronic respiratory symptoms in the ﬁrst 2 decades
of life. Interestingly the study of Perry and King in
19401 found that over 70% of patients had symp-
toms that commenced in childhood. Although
childhood for most subjects was characterised by
regular medical attendances for recurrent respira-
tory symptoms, in over half of cases subjects were
not aware of any speciﬁc medical diagnosis. The
most common diagnoses made in childhood were
asthma and wheezy bronchitis. Many of the
patients in this group described their symptoms
improving in early adulthood and then becoming
worse after the age of 50 possibly reﬂecting a
waning in immune function.
There has been a lack of information assessing
factors associated with FEV1 levels in bronchiecta-
sis. Two factors that are known to be associated
with poorer lung function in bronchiectasis are;
colonisation with P. aeruginosa,20 and extensive
disease on HRCT.15 In COPD factors associated with
low FEV1 levels include in addition to smoking;
frequency of exacerbations and airway hyper-responsiveness.5 Whooping cough and pneumonia
in childhood have been shown to be associated with
a small decrease in adult FEV1 (70 and 126ml).
21
In this cohort of subjects with bronchiectasis
there was a signiﬁcant correlation between low
FEV1 and smoking, extent of disease on X-ray and
isolation of Pseudomonas in the sputum. In view of
the literature these ﬁndings were not surprising.
The typical proﬁle of bronchiectasis in this group
of patients was of longstanding productive cough,
rhinosinusitis and fatigue in non-smokers with
crackles on chest auscultation. Such a clinical
picture strongly suggests the diagnosis of bronch-
iectasis and HRCT should be considered in such
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